<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ImmunoGen Inc. | Company News & Executive Profiles - IMGN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/immunogen+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for ImmunoGen Inc.]]></description>
	<s:counts start="0" returned="10" found="22" />
	<language>en-us</language>
	<item>
		<title><![CDATA[ImmunoGen, Inc. F3Q09 (Quarter End 03/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-293925.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Joel Sendek with Lazard Capital Markets.  Joel Sendek - Lazard Capital Markets  Given the fact that the agiment data for colon for Avastin didn&#8217;t work and you have a program moving forward with DM1 and agiment breast,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Apr 2009 17:05:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/business+model.html"><![CDATA[Business Model]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">IMGN</category>
	</item>
	<item>
		<title><![CDATA[Immunogen: Moving on Up]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F128181-immunogen-moving-on-up%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[David Rau submits: As evidenced by the volume of shares traded, [[IMGN]] still has not caught the fancy of investors or traders of substance.  IMGN has moved up smartly from month ago lows of 4 dollars and is now trading in the $7 range.  The volume remains around...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 27 Mar 2009 01:33:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/david+rau.html"><![CDATA[David Rau]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[ImmunoGen, Inc. F2Q09 (Qtr End 12/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-269882.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  We will take our first question from Shiv Kapoor with Morgan Joseph. Shiv Kapoor &#8211; Morgan Joseph & Company Congratulations on the strong operating cash flow this quarter.  I am going to ask some partner-related questions, and then I will get back in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 17 Feb 2009 10:22:14 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[Partnership]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F113408-genentech-s-trastuzumab-dm1-shows-great-promise-in-treating-breast-cancer%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[David Rau submits: Now that the SABC San Antonio Breast Cancer Conference is over, and the new year is upon us, what have we learned. Genentech DNA just announced data for the most promising oncology product in its pipeline, Trastuzumab-Dm1, or TDM-1. TDM-1 is a next generation treatment for Metastatic...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 06 Jan 2009 04:35:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/david+rau.html"><![CDATA[David Rau]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[Time to Buy ImmunoGen]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F109144-time-to-buy-immunogen%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[David Rau submits: With the overall stock market and the economy in shambles, is it time to start looking at beaten-down biotechs for large percentage moves.  My choice for huge upside growth is ImmunoGen IMGN.  As many know, Genentech DNA recently announced that trastuzumab-dm1 will enter a pivotal...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 04 Dec 2008 01:50:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/david+rau.html"><![CDATA[David Rau]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">IMGN</category>
	</item>
	<item>
		<title><![CDATA[ImmunoGen, Inc. F1Q09, (Qtr End 9/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-244172.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you.  [Operator instructions].  And we will go to Joel Sendek with Lazard Capital Markets. Joel Sendek Hi, thanks.  So I have a few questions.  First, one on just the AVE1642 study.  Is that a single agent study or is that controlled...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 27 Oct 2008 17:15:29 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agent.html"><![CDATA[Agent]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[Real Estate]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/agent.html"><![CDATA[Agent]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/real+estate.html"><![CDATA[Real Estate]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">IMGN</category>
	</item>
	<item>
		<title><![CDATA[Why It's Time to Buy More Immunogen]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F100391-why-it-s-time-to-buy-more-immunogen%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: Investing, particularly in biotech, comes with plenty of risks and uncertainties. These uncertainties are usually results of clinical trials, which are very unpredictable and unfortunately do not end up well in most cases.  Once in a while, a company and its stock price diverge in a way...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 17 Oct 2008 01:44:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/risk.html"><![CDATA[Risk]]></category>
		<category domain="http://resources.bnet.com/topic/stock+price.html"><![CDATA[Stock Price]]></category>
		<category domain="http://resources.bnet.com/topic/uncertainty.html"><![CDATA[Uncertainty]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[Genentech's Decision Should Boost Immunogen Stock]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F100025-genentech-s-decision-should-boost-immunogen-stock%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: It finally happened. Yesterday, Genentech  DNA announced that they made a "go" decision to advance T-DM1  into a phase III trial. Although no official announcement is out as  of yet, Genentech's President of Product Development, Sue Hellmann,  left no doubt in her prepared...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 15 Oct 2008 07:53:29 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/product+marketing.html"><![CDATA[Product Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[ImmunoGen, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223465.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions We will take our first question from Brian Rye of Janney Montgomery. Brian Rye &#8211; Janney Montgomery Well, good afternoon, guys, and congratulations on the year and thanks for taking my question. Really, just one question I guess, Mitch, in talking about the new &#8211;...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 08 Sep 2008 19:14:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">IMGN</category>
	</item>
	<item>
		<title><![CDATA[Genentech?s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89380-genentechs-new-adc-platform-has-much-potential-but-is-yet-to-be-tested-on-humans%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: On June 18th, Seattle Genetics SGEN announced it had received a milestone payment from Genentech DNA after the latter filed an IND Investigational New Drug application for an antibody-drug conjugate [ADC] powered by Seattle Genetics&#8217; technology.  Intriguingly, there was no additional data about the new agent, nor...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 Aug 2008 02:46:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">DNA,IMGN,SGEN</category>
	</item>
</channel>
</rss>
